Salute Notizie: 7 Agosto 2025 - 20 Settembre 2025

January 13, 2026, 7:30 AM EST. Eli Lilly and Nvidia unveiled a five-year, up to $1 billion collaboration to build an AI-powered laboratory aimed at accelerating drug discovery and development. The facility, in the San Francisco Bay Area, will use Nvidia's BioNeMo platform and its Vera Rubin computing architecture, plus robotics and physical AI tools to move candidates from research to production. Lilly and Nvidia said the program will fuse Lilly's data and scientific expertise with Nvidia's computing power to analyze large biological and chemical datasets more quickly. Nvidia CEO Jensen Huang said AI is reshaping industries, with life sciences among the most promising. Lilly CEO David Ricks said the venture seeks a startup-like environment to unlock breakthroughs neither company could achieve alone. The deal underscores pharma's shift toward AI to shorten timelines.